Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY4064809 food effect and PPI interaction study in healthy volunteers
NCT06991179Phase 1Completed
- Sponsor
- Eli Lilly and Company
- Start
- May 2025
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tersolisib (4 arms), sponsored by Eli Lilly and Company. Primary endpoints: Maximum Concentration of LY4064809, Area Under the Concentration versus Time Curve from Time Zero to Time T and 1 more. Started May 2025; status: completed.
02
Drugs
tersolisib
Beyond the preview
Go deeper on NCT06991179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06991179.